img_hblbg.jpg
logo.jpg
img_hbrbg.jpg
inmbtn01o.jpg
menu_blank.png
menu_blank.png
menu_blank.png
menu_blank.png
img_blueB.jpg
img_blueB.jpg
img_inp_rblbg.jpg

Latest @ Ipca

Ipca - Ratlam formulations plant ranked third position in the National Energy Conservation Award - 2010.

img_inp_rblbg.jpg

APIs

Ipca has emerged as one of India's top exporters of APIs with nearly 25% of the turnover coming from APIs. Regulated markets like the USA, Canada, Europe and Australia account for 75% of our API exports.

We are one of the world's largest manufacturers of APIs - Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Furosemide (diuretic), Hydroxychloroquine Sulphate (NSAID), Metoprolol Succinate (anti-hypertensive), Metoprolol Tartrate (anti-hypertensive) and Pyrantel Salts (anthelmintic) - besides being one of the largest suppliers of these APIs worldwide.

For over 20 years, Ipca has been playing a lead role in the Indian APIs market, both in the anti-malarial and anti-hypertensive therapeutic segments. We are the first manufacturer in India for APIs like Atenolol, Hydroxycholoquine Sulphate, Morantel Citrate, Pyrantel Pamoate and Zaltoprofen.

Our domestic pharmaceutical customers include pharmaceutical majors like Abbott, AstraZeneca, Bayer, Cipla, Dr. Reddy's, Merck, Pfizer, Ranbaxy, and Wockhardt.

icon_06.png
One of India's top exporters
of APIs
icon_07.png
Lead role in Indian APIs market, in anti-malarial and anti-hypertensive segments
icon_02.png
First manufacturer in India for APIs like Atenolol, Hydroxycholoquine Sulphate, Morantel Citrate, Pyrantel Pamoate and Zaltoprofen
Copyright © Ipca Laboratories Ltd. 2012. All Rights Reserved.